SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MS drug tolebrutinib faces Long-Term safety check in 2,500 patients
Disease control OngoingThis study checks the long-term safety of the drug tolebrutinib in about 2,500 adults with multiple sclerosis who were in earlier trials. Participants take the drug for up to several years while doctors watch for side effects and track disability. The goal is to see if the drug r…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
Diet and calorie cutting may ease MS symptoms, new study hopes to prove
Symptom relief OngoingThis study looks at whether eating a better diet and cutting calories can improve physical function, thinking, pain, fatigue, mood, and anxiety in 100 adults with multiple sclerosis. Participants have relapsing-remitting or secondary progressive MS and are overweight or obese. Re…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 03:54 UTC